Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment. Caporro M, Disanto G, Gobbi C, Zecca C Patient Prefer Adherence. 2014; 8:1123-34. Epub 2014 Aug 21. PMID: 25170258. Abstract CommentRecommendBookmarkWatch